Abstract: Rheumatoid arthritis (RA), an autoimmune disease characterized by chronic inflammation of synovial tissue, is divided into two subtypes—anti-citrullinated protein antibody (ACPA)-positive and ACPA-negative RA. While the pathogenic mechanisms of ACPA-positive RA are well-understood, the etiology of ACPA-negative RA remains largely unknown. The association between RA and periodontitis (PD) has been observed since the early 1900s, with the two diseases sharing common genetic and environmental risk factors that lead to the progressive destruction of bone and connective tissue. However, the associations between PD and the two subtypes of RA differ. This comprehensive review aims to provide an updated understanding of the epidemiological association between RA and PD, explore potential pathogenic mechanisms linking the two diseases, and highlight the key distinctions between the subtypes of RA and their respective associations with PD. We also discuss the possibility of early intervention or the treatment of the two diseases. Ultimately, this review aims to provide valuable insights for future research in this field.

类风湿关节炎与牙周炎在流行病学及发病机制上的关联

[1]AletahaD, NeogiT, SilmanAJ, et al., 2010. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum, 62(9):2569-2581.

[2]AmkreutzJAMP, de MoelEC, TheanderL, et al., 2021. Association between bone mineral density and autoantibodies in patients with rheumatoid arthritis. Arthritis Rheumatol, 73(6):921-930.

[3]AndradeF, DarrahE, GucekM, et al., 2010. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum, 62(6):1630-1640.

[4]AraújoVMA, MeloIM, LimaV, 2015. Relationship between periodontitis and rheumatoid arthritis: review of the literature. Mediators Inflamm, 2015:259074.

[5]ÄyräväinenL, HeikkinenAM, KuulialaA, et al., 2018. Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status. Ann Med, 50(4):333-344.

[6]BartoldPM, Lopez-OlivaI, 2020. Periodontitis and rheumatoid arthritis: an update 2012-2017. Periodontology 2000, 83(1):189-212.

[7]Bello-GualteroJM, LafaurieGI, HoyosLX, et al., 2016. Periodontal disease in individuals with a genetic risk of developing arthritis and early rheumatoid arthritis: a cross-sectional study. J Periodontol, 87(4):346-356.

[8]Castellar-MendozaC, CastilloDM, Chila-MorenoL, et al., 2023. Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis. Clin Oral Invest, 27(7):3509-3519.

[9]CheahCW, Al-MalekiAR, VadiveluJ, et al., 2020. Salivary and serum cathelicidin LL-37 levels in subjects with rheumatoid arthritis and chronic periodontitis. Int J Rheum Dis, 23(10):1344-1352.

[10]CheahCW, Al-MalekiAR, VaithilingamRD, et al., 2022. Associations between inflammation-related LL-37 with subgingival microbial dysbiosis in rheumatoid arthritis patients. Clin Oral Invest, 26(5):4161-4172.

[11]ChenQM, WangYH, ShuaiJ, 2023. Current status and future prospects of stomatology research. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 24(10):853-867.

[12]CorrêaJD, FernandesGR, CalderaroDC, et al., 2019. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients. Sci Rep, 9:8379.

[13]CosgareaR, TristiuR, DumitruRB, et al., 2019. Effects of non-surgical periodontal therapy on periodontal laboratory and clinical data as well as on disease activity in patients with rheumatoid arthritis. Clin Oral Invest, 23(1):141-151.

[14]de AquinoSG, TalbotJ, SônegoF, et al., 2017. The aggravation of arthritis by periodontitis is dependent of IL-17 receptor A activation. J Clin Periodontol, 44(9):881-891.

[15]de MolonRS, RossaCJr, ThurlingsRM, et al., 2019. Linkage of periodontitis and rheumatoid arthritis: current evidence and potential biological interactions. Int J Mol Sci, 20(18):4541.

[16]DemmerRT, MolitorJA, JacobsDRJr, et al., 2011. Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the first national health and nutrition examination survey and its epidemiological follow-up study. J Clin Periodontol, 38(11):998-1006.

[17]DetertJ, PischonN, BurmesterGR, et al., 2010. The association between rheumatoid arthritis and periodontal disease. Arthritis Res Ther, 12(5):218.

[18]di BenedettoA, GiganteI, ColucciS, et al., 2013. Periodontal disease: linking the primary inflammation to bone loss. Clin Dev Immunol, 2013:503754.

[19]ErikssonK, FeiGZ, LundmarkA, et al., 2019. Periodontal health and oral microbiota in patients with rheumatoid arthritis. J Clin Med, 8(5):630.

[20]ErikssonK, LundmarkA, DelgadoLF, et al., 2022. Salivary microbiota and host-inflammatory responses in periodontitis affected individuals with and without rheumatoid arthritis. Front Cell Infect Microbiol, 12:841139.

[21]FeldmannM, BrennanFM, MainiRN, 1996. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol, 14:397-440.

[22]FiresteinGS, 2003. Evolving concepts of rheumatoid arthritis. Nature, 423(6937):356-361.

[23]FiresteinGS, McInnesIB, 2017. Immunopathogenesis of rheumatoid arthritis. Immunity, 46(2):183-196.

[24]GabarriniG, de SmitM, WestraJ, et al., 2015. The peptidylarginine deiminase gene is a conserved feature of Porphyromonas gingivalis. Sci Rep, 5:13936.

[25]GehlotP, VolkSL, RiosHF, et al., 2016. Spontaneous destructive periodontitis and skeletal bone damage in transgenic mice carrying a human shared epitope-coding HLA-DRB1 allele. RMD Open, 2(2):e000349.

[26]GolubLM, PayneJB, ReinhardtRA, et al., 2006. Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical “two-hit” model. J Dent Res, 85(2):102-105.

[27]González-FeblesJ, SanzM, 2021. Periodontitis and rheumatoid arthritis: what have we learned about their connection and their treatment? Periodontology 2000, 87(1):181-203.

[28]GorrSU, AbdolhosseiniM, 2011. Antimicrobial peptides and periodontal disease. J Clin Periodontol, 38(Suppl 11):126-141.

[29]GriffenAL, BeallCJ, CampbellJH, et al., 2012. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J, 6(6):1176-1185.

[30]Guzmán-GuzmánIP, Ramírez-VélezCI, Falfán-ValenciaR, et al., 2021. PADI2 polymorphisms are significantly associated with rheumatoid arthritis, autoantibodies serologic status and joint damage in women from southern Mexico. Front Immunol, 12:718246.

[31]HajishengallisG, LiXF, DivarisK, et al., 2022. Maladaptive trained immunity and clonal hematopoiesis as potential mechanistic links between periodontitis and inflammatory comorbidities. Periodontology 2000, 89(1):215-230.

[32]HaroI, SanmartíR, GómaraMJ, 2022. Implications of post-translational modifications in autoimmunity with emphasis on citrullination, homocitrullination and acetylation for the pathogenesis, diagnosis and prognosis of rheumatoid arthritis. Int J Mol Sci, 23(24):15803.

[33]HeasmanL, StaceyF, PreshawPM, et al., 2006. The effect of smoking on periodontal treatment response: a review of clinical evidence. J Clin Periodontol, 33(4):241-253.

[34]HoltSC, KesavaluL, WalkerS, et al., 1999. Virulence factors of Porphyromonas gingivalis. Periodontology 2000, 20(1):168-238.

[35]HowKY, SongKP, ChanKG, 2016. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol, 7:53.

[36]JavedF, AhmedHB, MikamiT, et al., 2014. Cytokine profile in the gingival crevicular fluid of rheumatoid arthritis patients with chronic periodontitis. J Invest Clin Dent, 5(1):1-8.

[37]JenningM, MarkleinB, YtterbergJ, et al., 2020. Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection—a missing link for ACPA production. Ann Rheum Dis, 79(9):1194-1202.

[38]JohanssonA, 2011. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins, 3(3):242-259.

[39]JohanssonL, SherinaN, KharlamovaN, et al., 2016. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis. Arthritis Res Ther, 18:201.

[40]KaurS, BrightR, ProudmanSM, et al., 2014. Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Semin Arthritis Rheum, 44(2):113-122.

[41]KharlamovaN, JiangX, SherinaN, et al., 2016. Antibodies to Porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology. Arthritis Rheumatol, 68(3):604-613.

[42]KobayashiT, YokoyamaT, ItoS, et al., 2014. Periodontal and serum protein profiles in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitor adalimumab. J Periodontol, 85(11):1480-1488.

[43]KobayashiT, ItoS, KobayashiD, et al., 2015. Interleukin-6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors. Clin Exp Dent Res, 1(2):63-73.

[44]KonigMF, AndradeF, 2016. A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination. Front Immunol, 7:461.

[45]KonigMF, ParachaAS, MoniM, et al., 2015. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology. Ann Rheum Dis, 74(11):2054-2061.

[46]KonigMF, AbuslemeL, ReinholdtJ, et al., 2016. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med, 8(369):369ra176.

[47]KönönenE, MüllerHP, 2014. Microbiology of aggressive periodontitis. Periodontology 2000, 65(1):46-78.

[48]KorkmazC, UsT, KaşifoğluT, et al., 2006. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem, 39(10):961-965.

[49]KroeseJM, BrandtBW, BuijsMJ, et al., 2021. Differences in the oral microbiome in patients with early rheumatoid arthritis and individuals at risk of rheumatoid arthritis compared to healthy individuals. Arthritis Rheumatol, 73(11):1986-1993.

[50]KrutyhołowaA, StrzelecK, DziedzicA, et al., 2022. Host and bacterial factors linking periodontitis and rheumatoid arthritis. Front Immunol, 13:980805.

[51]KwonEJ, JuJH, 2021. Impact of posttranslational modification in pathogenesis of rheumatoid arthritis: focusing on citrullination, carbamylation, and acetylation. Int J Mol Sci, 22(19):10576.

[52]LappinDF, ApatzidouD, QuirkeAM, et al., 2013. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol, 40(10):907-915.

[53]LaugischO, WongA, SrokaA, et al., 2016. Citrullination in the periodontium—a possible link between periodontitis and rheumatoid arthritis. Clin Oral Invest, 20(4):675-683.

[54]LaurentL, AnquetilF, ClavelC, et al., 2015. IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies. Ann Rheum Dis, 74(7):1425-1431.

[55]LiKT, MoWX, WuLJ, et al., 2021. Novel autoantibodies identified in ACPA-negative rheumatoid arthritis. Ann Rheum Dis, 80(6):739-747.

[56]LiKT, WangM, ZhaoLD, et al., 2022. ACPA-negative rheumatoid arthritis: from immune mechanisms to clinical translation. eBioMedicine, 83:104233.

[57]LiS, YuYS, YueYS, et al., 2016. Autoantibodies from single circulating plasmablasts react with citrullinated antigens and Porphyromonas gingivalis in rheumatoid arthritis. Arthritis Rheumatol, 68(3):614-626.

[58]LiS, SchmalzG, SchmidtJ, et al., 2018. Antimicrobial peptides as a possible interlink between periodontal diseases and its risk factors: a systematic review. J Periodontal Res, 53(2):145-155.

[59]LiXF, WangH, YuX, et al., 2022. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell, 185(10):1709-1727.e18.

[60]LinhartováI, BumbaL, MašínJ, et al., 2010. RTX proteins: a highly diverse family secreted by a common mechanism. FEMS Microbiol Rev, 34(6):1076-1112.

[61]Linn-RaskerSP, van der Helm-van Mil AHM, van GaalenFA, et al., 2006. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis, 65(3):366-371.

[62]LobognonVD, AlardJE, 2022. Could AMPs and B-cells be the missing link in understanding periodontitis? Front Immunol, 13:887147.

[63]LoohSC, SooZMP, WongJJ, et al., 2022. Aggregatibacter actinomycetemcomitans as the aetiological cause of rheumatoid arthritis: what are the unsolved puzzles? Toxins, 14(1):50.

[64]LundströmE, KällbergH, AlfredssonL, et al., 2009. Gene‒environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody‒positive rheumatoid arthritis: all alleles are important. Arthritis Rheum, 60(6):1597-1603.

[65]MankiaK, ChengZJ, DoT, et al., 2019. Prevalence of periodontal disease and periodontopathic bacteria in anti-cyclic citrullinated protein antibody-positive at-risk adults without arthritis. JAMA Netw Open, 2(6):e195394.

[66]MarietteX, PerrodeauE, VernerC, et al., 2020. Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort. Rheumatology, 59(5):988-996.

[67]MarshPD, 1994. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res, 8(2):263-271.

[68]Martin-MolaE, BalsaA, García-VicunaR, et al., 2016. Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review. Rheumatol Int, 36(8):1043-1063.

[69]MassarentiL, EnevoldC, DamgaardD, et al., 2021. PADI4 polymorphisms confer risk of anti-CCP-positive rheumatoid arthritis in synergy with HLA-DRB1*04 and smoking. Front Immunol, 12:707690.

[70]MassarentiL, EnevoldC, DamgaardD, et al., 2022. Peptidylarginine deiminase 2 gene polymorphisms in subjects with periodontitis predispose to rheumatoid arthritis. Int J Mol Sci, 23(17):9536.

[71]MayerY, ElimelechR, Balbir-GurmanA, et al., 2013. Periodontal condition of patients with autoimmune diseases and the effect of anti-tumor necrosis factor-α therapy. J Periodontol, 84(2):136-142.

[72]MikulsTR, PayneJB, YuF, et al., 2014. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol, 66(5):1090-1100.

[73]MukherjeeA, JantschV, KhanR, et al., 2018. Rheumatoid arthritis-associated autoimmunity due to Aggregatibacter actinomycetemcomitans and its resolution with antibiotic therapy. Front Immunol, 9:2352.

[74]Muñoz-AtienzaE, FlakMB, SirrJ, et al., 2020. The P. gingivalis autocitrullinome is not a target for ACPA in early rheumatoid arthritis. J Dent Res, 99(4):456-462.

[75]NesseW, WestraJ, van der WalJE, et al., 2012. The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. J Clin Periodontol, 39(7):599-607.

[76]OliveiraSR, de ArrudaJAA, SchneiderAH, et al., 2021. Are neutrophil extracellular traps the link for the cross-talk between periodontitis and rheumatoid arthritis physiopathology? Rheumatology, 61(1):174-184.

[77]PapapanouPN, SanzM, BuduneliN, et al., 2018. Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol, 89(Suppl 1):S173-S182.

[78]PersJO, SarauxA, PierreR, et al., 2008. Anti-TNF-α immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J Periodontol, 79(9):1645-1651.

[79]PotempaJ, MydelP, KozielJ, 2017. The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nat Rev Rheumatol, 13(10):606-620.

[80]QuirkeAM, LugliEB, WegnerN, et al., 2014. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis, 73(1):263-269.

[81]RiesC, 2014. Cytokine functions of TIMP-1. Cell Mol Life Sci, 71(4):659-672.

[82]RoeleveldDM, KoendersMI, 2015. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy. Cytokine, 74(1):101-107.

[83]RomeroV, Fert-BoberJ, NigrovicPA, et al., 2013. Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci Transl Med, 5(209):209ra150.

[84]RönnelidJ, TuressonC, KastbomA, 2021. Autoantibodies in rheumatoid arthritis ‒ laboratory and clinical perspectives. Front Immunol, 12:685312.

[85]SakkasLI, BogdanosDP, KatsiariC, et al., 2014. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment. Autoimmun Rev, 13(11):1114-1120.

[86]SchellekensGA, deJong BA, van den HoogenFH, et al., 1998. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest, 101(1):273-281.

[87]SchererHU, HäuplT, BurmesterGR, 2020. The etiology of rheumatoid arthritis. J Autoimmun, 110:102400.

[88]ShimadaA, KobayashiT, ItoS, et al., 2016. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis. J Periodontal Res, 51(1):103-111.

[89]SilosiI, CojocaruM, FoiaL, et al., 2015. Significance of circulating and crevicular matrix metalloproteinase-9 in rheumatoid arthritis-chronic periodontitis association. J Immunol Res, 2015:218060.

[90]SilvaDS, CostaF, BaptistaIP, et al., 2022. Evidence-based research on effectiveness of periodontal treatment in rheumatoid arthritis patients: a systematic review and meta-analysis. Arthritis Care Res, 74(10):1723-1735.

[91]SmolenJS, AletahaD, McInnesIB, 2016. Rheumatoid arthritis. Lancet, 388(10055):2023-2038.

[92]SocranskySS, HaffajeeAD, 1994. Evidence of bacterial etiology: a historical perspective. Periodontology 2000, 5(1):7-25.

[93]SokoloveJ, SchiffM, FleischmannR, et al., 2016. Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial. Ann Rheum Dis, 75(4):709-714.

[94]SparksJA, 2019. Rheumatoid arthritis. Ann Intern Med, 170(1):ITC1-ITC16.

[95]SuzukiA, YamadaR, ChangXT, et al., 2003. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet, 34(4):395-402.

[96]SuzukiN, YonedaM, HirofujiT, 2013. Mixed red-complex bacterial infection in periodontitis. Int J Dent, 2013:587279.

[97]TangQQ, FuHT, QinBD, et al., 2017. A possible link between rheumatoid arthritis and periodontitis: a systematic review and meta-analysis. Int J Periodontics Restorative Dent, 37(1):79-86.

[98]TongYL, ZhengLL, QingPY, et al., 2020. Oral microbiota perturbations are linked to high risk for rheumatoid arthritis. Front Cell Infect Microbiol, 9:475.

[99]TooCL, MuradS, DhaliwalJS, et al., 2012. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis. Arthritis Res Ther, 14(6):R250.

[100]van WinkelhoffAJ, Bosch-TijhofCJ, WinkelEG, et al., 2001. Smoking affects the subgingival microflora in periodontitis. J Periodontol, 72(5):666-671.

[101]VerpoortKN, van GaalenFA, van der Helm-van Mil AHM, et al., 2005. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum, 52(10):3058-3062.

[102]WegnerN, WaitR, SrokaA, et al., 2010. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum, 62(9):2662-2672.

[103]WillemzeA, TrouwLA, ToesREM, et al., 2012. The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol, 8(3):144-152.

[104]WoelberJP, Al-AhmadA, AltKW, 2022. On the pathogenicity of the oral biofilm: a critical review from a biological, evolutionary, and nutritional point of view. Nutrients, 14(10):2174.

[105]ZhangX, ZhangDY, JiaHJ, et al., 2015. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med, 21(8):895-905.

[106]ZhaoXT, LinHB, DingT, et al., 2023. Overview of the main biological mechanisms linked to changes in periodontal ligament stem cells and the inflammatory microenvironment. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 24(5):373-386.

[107]ZiebolzD, RupprechtA, SchmicklerJ, et al., 2018. Association of different immunosuppressive medications with periodontal condition in patients with rheumatoid arthritis: results from a cross-sectional study. J Periodontol, 89(11):1310-1317.